- Home
- AMIX vs IBO Comparison
AMIX vs IBO Comparison
Compare AMIX & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMIX
- IBO
- Stock Information
- Founded
- AMIX 2014
- IBO 2018
- Country
- AMIX United States
- IBO United States
- Employees
- AMIX N/A
- IBO N/A
- Industry
- AMIX
- IBO
- Sector
- AMIX
- IBO
- Exchange
- AMIX NYSE
- IBO NYSE
- Market Cap
- AMIX 4.9M
- IBO 5.1M
- IPO Year
- AMIX N/A
- IBO 2024
- Fundamental
- Price
- AMIX $1.95
- IBO $0.54
- Analyst Decision
- AMIX Strong Buy
- IBO
- Analyst Count
- AMIX 1
- IBO 0
- Target Price
- AMIX $5.00
- IBO N/A
- AVG Volume (30 Days)
- AMIX 347.1K
- IBO 10.6M
- Earning Date
- AMIX 05-30-2025
- IBO 05-27-2025
- Dividend Yield
- AMIX N/A
- IBO N/A
- EPS Growth
- AMIX N/A
- IBO N/A
- EPS
- AMIX N/A
- IBO N/A
- Revenue
- AMIX N/A
- IBO N/A
- Revenue This Year
- AMIX N/A
- IBO N/A
- Revenue Next Year
- AMIX N/A
- IBO N/A
- P/E Ratio
- AMIX N/A
- IBO N/A
- Revenue Growth
- AMIX N/A
- IBO N/A
- 52 Week Low
- AMIX $1.52
- IBO $0.37
- 52 Week High
- AMIX $75.80
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- AMIX 50.80
- IBO N/A
- Support Level
- AMIX $1.67
- IBO N/A
- Resistance Level
- AMIX $1.96
- IBO N/A
- Average True Range (ATR)
- AMIX 0.21
- IBO 0.00
- MACD
- AMIX -0.01
- IBO 0.00
- Stochastic Oscillator
- AMIX 24.35
- IBO 0.00
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing innovative technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.